NovoCure Ltd

For the period ended Mar 31, 2025. Filed Apr 24, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed Apr 24, 2025

NVCR$12.53-5.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Item 6. Exhibits

EXHIBIT INDEX

ExhibitNumber				Incorporated by Reference		FiledHerewith
	Exhibit Description		Form		Date		Number
10.1		Employment Agreement between Uri Weinberg and Novocure GmbH effective as of August 1, 2024#						X
31.1		Certification of Principal Executive Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended						X
31.2		Certification of Principal Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended						X
32.1*		Certification of Principal Executive Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350						X
32.2*		Certification of Principal Financial Officer Required Under Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350						X
101.INS		Inline XBRL Instance Document						X
101.SCH		Inline XBRL Taxonomy Extension Schema Document						X
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document						X
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document						X
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document						X
101.PRE		Inline XBRL Extension Presentation Linkbase Document						X
104		Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101)						X

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.